1,323
Views
49
CrossRef citations to date
0
Altmetric
Research Article

Silica, Apoptosis, and Autoimmunity

, , &
Pages 177-187 | Received 19 Aug 2004, Accepted 12 Nov 2004, Published online: 09 Oct 2008

REFERENCES

  • Albert M. L., Pearce S. F., Francisco L. M., Sauter B., Roy P., Silverstein R. L., Bhardwaj N. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T-lymphocytes. J. Exp. Med. 1998; 188(7)1359–1368
  • Barton A., Lamb R., Symmons D., Silman A., Thomson W., Worthington J., Donn R. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun. 2003; 4(7)487–491
  • Bertho N., Blancheteau V. M., Setterblad N., Laupeze B., Lord J. M., Drenou B., Amiot L., Charron D. J., Fauchet R., Mooney N. MHC class II-mediated apoptosis of mature dendritic cells proceeds by activation of the protein kinase C-delta isoenzyme. Int. Immunol 2002; 14(8)935–942
  • Boatright K. M., Salvesen G. S. Mechanisms of caspase activation. Curr. Opin. Cell. Biol. 2003; 15(6)725–731
  • Borges V. M., Lopes M. F., Falcao H., Leite-Junior J. H., Rocco P. R., Davidson W. F., Linden R., Zin W. A., DosReis G. A. Apoptosis underlies immunopathogenic mechanisms in acute silicosis. Amer. J. Respir. Cell. Mol. Biol 2002; 27(1)78–84
  • Bramwell B. Diffuse scleroderma: Its frequency; its occurrence in stone masons; its treatment by fibrolysis. Edinburgh Med. J 1914; 12: 387
  • Brodie C., Blumberg P. M. Regulation of cell apoptosis by protein kinase c delta. Apoptosis 2003; 8(1)19–27
  • Brody A. R., Roe M. W., Evans J. N., Davis G. S. Deposition and translocation of inhaled silica in rats. Quantification of particle distribution, macrophage participation, and function. Lab. Invest 1982; 47(6)533–542
  • Brown J. M., Pfau J. C., Holian A. Immunoglobulin and lymphocyte responses following silica exposure in New Zealand mixed mice. Inhal. Toxicol 2004; 16(3)133–139
  • Calandra T., Roger T. Macrophage migration inhibitory factor: A regulator of innate immunity. Nat. Rev. Immunol 2003; 3(10)791–800
  • Caplan A. Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax 1953; 8(1)29–37
  • Casciola-Rosen L., Wigley F., Rosen A. Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: Implications for pathogenesis. J. Exp. Med 1997; 185(1)71–79
  • Castranova V. D., Vallyathan V. Role of Surface Free Radicals in the Pathogenicity of Silicosis: Silica and Silica-Induced Lung Diseases. CRC Press, Florida 1996
  • Chao S. K., Hamilton R. F., Pfau J. C., Holian A. Cell surface regulation of silica-induced apoptosis by the SR-A scavenger receptor in a murine lung macrophage cell line (MH-S). Toxicol. Appl. Pharmacol. 2001; 174(1)10–16
  • Cohen P. L., Eisenberg R. A. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 1991; 9: 243–269
  • Cooper G. S., Miller F. W., Germolec D. R. Occupational exposures and autoimmune diseases. Int. Immunopharmacol. 2002; 2(2-3)303–13
  • Creagh E. M., Conroy H., Martin S. J. Caspase-activation pathways in apoptosis and immunity. Immunol. Rev. 2003; 193: 10–21
  • Davis G. S., Holmes C. E., Pfeiffer L. M., Hemenway D. R. Lymphocytes, lymphokines, and silicosis. J. Environ. Pathol. Toxicol. Oncol. 2001; 20: 53–65, Suppl 1
  • Davis G. S., Leslie K. O., Hemenway D. R. Silicosis in mice: Effects of dose, time, and genetic strain. J. Environ. Pathol. Toxicol. Oncol. 1998; 17(2)81–97
  • Davis G. S., Pfeiffer L. M., Hemenway D. R. Persistent overexpression of interleukin-1beta and tumor necrosis factor-alpha in murine silicosis. J. Environ. Pathol. Toxicol. Oncol. 1998; 17: 99–114
  • Davis G. S., Pfeiffer L. M., Hemenway D. R. Interferon-gamma production by specific lung lymphocyte phenotypes in silicosis in mice. Am. J. Respir. Cell. Mol. Biol. 2000; 22(4)491–501
  • Donn R., Alourfi Z., Zeggini E., Lamb R., Jury F., Lunt M., Meazza C., De Benedetti F., Thomson W., Ray D. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum 2004; 50(5)1604–1610
  • Fadok V. A., Bratton D. L., Konowal A., Freed P. W., Westcott J. Y., Henson P. M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest 1998; 101(4)890–898
  • Foote A., Briganti E. M., Kipen Y., Santos L., Leech M., Morand E. F. Macrophage migration inhibitory factor in systemic lupus erythematosus. J. Rheumatol 2004; 31(2)268–273
  • Friedetzky A., Garn H., Kirchner A., Gemsa D. Histopathological changes in enlarged thoracic lymph nodes during the development of silicosis in rats. Immunobiology 1998; 199(1)119–132
  • Garn H., Friedetzky A., Davis G. S., Hemenway D. R., Gemsa D. T-lymphocyte activation in the enlarged thoracic lymph nodes of rats with silicosis. Am. J. Respir. Cell. Mol. Biol. 1997; 16(3)309–316
  • Garn H., Friedetzky A., Kirchner A., Jager R., Gemsa D. Experimental silicosis: A shift to a preferential IFN-gamma-based Th1 response in thoracic lymph nodes. Am. J. Physiol. Lung. Cell. Mol. Physiol 2000; 278(6)L1221–1230
  • Greidinger E. L. Apoptosis in lupus pathogenesis. Front. Biosci 2001; 6: D1392–1402
  • Gumireddy K., Reddy C. D., Swamy N. Mitogen-activated protein kinase pathway mediates DBP-maf-induced apoptosis in RAW 264.7 macrophages. J. Cell. Biochem 2003; 90(1)87–96
  • Gutierrez-Pabello J. A., McMurray D. N., Adams L. G. Upregulation of thymosin beta-10 by Mycobacterium bovis infection of bovine macrophages is associated with apoptosis. Infect. Immun 2002; 70(4)2121–2127
  • Hall A. K. Thymosin beta-10 accelerates apoptosis. Cell. Mol. Biol. Res 1995; 41(3)167–180
  • Hamilton R. F., Iyer L. L., Holian A. Asbestos induces apoptosis in human alveolar macrophages. Am. J. Physiol 1996; 271(5)L813–819, Pt 1
  • Hamilton R. F., Jr., Pfau J. C., Marshall G. D., Holian A. Silica and PM1648 modify human alveolar macrophage antigen-presenting cell activity in vitro. J. Environ. Pathol. Toxicol. Oncol 2001; 20: 75–84, Suppl 1
  • Hamzaoui A., Ammar J., Grairi H., Hamzaoui K. Expression of Fas antigen and Fas ligand in bronchoalveolar lavage from silicosis patients. Mediators Inflamm 2003; 12(4)209–214
  • Hanayama R., Tanaka M., Miyasaka K., Aozasa K., Koike M., Uchiyama Y., Nagata S. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 2004; 304(5674)1147–1150
  • Hogan S. L., Satterly K. K., Dooley M. A., Nachman P. H., Jennette J. C., Falk R. J. Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J. Am. Soc. Nephrol 2001; 12(1)134–142
  • Holian A., Uthman M. O., Goltsova T., Brown S. D., Hamilton R. F. Asbestos and silica-induced changes in human alveolar macrophage phenotype. Environ. Health Perspect 1997; 105(S5)1139–1142
  • Hubbard A. K. Role for T lymphocytes in silica-induced pulmonary inflammation. Lab. Invest 1989; 61(1)46–52
  • Hughes J. M., Jones R. N., Gilson J. C., Hammad Y. Y., Samimi B., Hendrick D. J., Turner-Warwick M., Doll N. J., Weill H. Determinants of progression in sandblasters' silicosis. Ann. Occup. Hyg 1982; 26(1-4)701–712
  • Hultman P., Enestrom S., Pollard K. M., Tan E. M. Anti-fibrillarin autoantibodies in mercury-treated mice. Clin. Exp. Immunol 1989; 78(3)470–477
  • Iyer R., Hamilton R. F., Li L., Holian A. Silica-induced apoptosis mediated via scavenger receptor in human alveolar macrophages. Toxicol. Appl. Pharmacol. 1996; 141: 84–92
  • Kobzik L. Lung macrophage uptake of unopsonized environmental particulates. Role of scavenger-type receptors. J. Immunol 1995; 155(1)367–376
  • Koeger A. C., Lang T., Alcaix D., Milleron B., Rozenberg S., Chaibi P., Arnaud J., Mayaud C., Camus J. P., Bourgeois P. Silica-associated connective tissue disease. A study of 24 cases. Medicine (Baltimore) 1995; 74(5)221–237
  • Krammer P. H. CD95's deadly mission in the immune system. Nature 2000; 407(6805)789–795
  • Krieger M. The other side of scavenger receptors: Pattern recognition for host defense. Curr Opin Lipidol 1997; 8(5)275–280
  • Lan H. Y., Yang N., Nikolic-Paterson D. J., Yu X. Q., Mu W., Isbel N. M., Metz C. N., Bucala R., Atkins R. C. Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 2000; 57(2)499–509
  • Leech M., Metz C., Hall P., Hutchinson P., Gianis K., Smith M., Weedon H., Holdsworth S. R., Bucala R., Morand E. F. Macrophage migration inhibitory factor in rheumatoid arthritis: Evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999; 42(8)1601–1608
  • Leigh J., Wang H. A. B., Peters M., Ruan X. Silica-induced apoptosis in aleolar and granulomatous cells in vivo. Environ. Health. Perspect 1997; 105(S5)1241–1245
  • Lounsbury K. M., Stern M., Taatjes D., Jaken S., Mossman B. T. Increased localization and substrate activation of protein kinase C delta in lung epithelial cells following exposure to asbestos. Am. J. Pathol 2002; 160(6)1991–2000
  • Lue H., Kleemann R., Calandra T., Roger T., Bernhagen J. Macrophage migration inhibitory factor (MIF): Mechanisms of action and role in disease. Microbes Infect 2002; 4(4)449–460
  • Mayes M. D. Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ. Health Perspect 1999; 107: 743–748, Suppl 5
  • McHugh N. J., Whyte J., Harvey G., Haustein U. F. Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity. Arthritis Rheum 1994; 37(8)1198–1205
  • Mevorach D., Zhou J. L., Song X., Elkon K. B. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med 1998; 188(2)387–392
  • Mohan C., Morel L., Yang P., Wakeland E. K. Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis Rheum 1998; 41(9)1652–1662
  • Morand E. F., Leech M., Weedon H., Metz C., Bucala R., Smith M. D. Macrophage migration inhibitory factor in rheumatoid arthritis: Clinical correlations. Rheumatology (Oxford) 2002; 41(5)558–562
  • Negorev D., Riethman H., Wechsler-Reya R., Sakamuro D., Prendergast G. C., Simon D. The Bin1 gene localizes to human chromosome 2q14 by PCR analysis of somatic cell hybrids and fluorescence in situ hybridization. Genomics 1996; 33(2)329–331
  • Nozawa K., Casiano C. A., Hamel J. C., Molinaro C., Fritzler M. J., Chan E. K. Fragmentation of Golgi complex and Golgi autoantigens during apoptosis and necrosis. Arthritis Res 2002; 4(4)R3
  • Ortiz L. A., Lasky J., Lungarella G., Cavarra E., Martorana P., Banks W. A., Peschon J. J., Schmidts H. L., Brody A. R., Friedman M. Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice. Am. J. Respir. Cell. Mol. Biol 1999; 20(4)825–833
  • Otsuki T., Sakaguchi H., Tomokuni A., Aikoh T., Matsuki T., Kawakami Y., Kusaka M., Ueki H., Kita S., Ueki A. Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology 1998; 94: 258–262
  • Parks C. G., Conrad K., Cooper G. S. Occupational exposure to crystalline silica and autoimmune disease. Environ. Health Perspect 1999; 107(S5)793–802
  • Parks C. G., Cooper G. S., Nylander-French L. A., Sanderson W. T., Dement J. M., Cohen P. L., Dooley M. A., Treadwell E. L., St Clair E. W., Gilkeson G. S., Hoppin J. A., Savitz D. A. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: A population-based, case-control study in the southeastern United States. Arthritis Rheum 2002; 46(7)1840–1850
  • Parks C. G., Cooper G. S., Nylander-French L. A., Storm J. F., Archer J. D. Assessing exposure to crystalline silica from farm work: A population-based study in the Southeastern United States. Ann. Epidemiol 2003; 13(5)385–392
  • Pernis B., Paronetto F. Adjuvant effects of silica (tridymite) on antibody production. Proc. Soc. Exp. Biol. Med. 1962; 110: 390–392
  • Pfau J. C., Brown J. M., Holian A. Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology 2004; 195(2-3)167–176
  • Pfeffer K. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev 2003; 14(3-4)185–191
  • Piguet P. F., Collart M. A., Grau G. E., Sappino A. P., Vassalli P. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 1990; 344(6263)245–247
  • Pollard K. M., Lee D. K., Casiano C. A., Bluthner M., Johnston M. M., Tan E. M. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. J. Immunol 1997; 158(7)3521–3528
  • Pongracz J., Webb P., Wang K., Deacon E., Lunn O. J., Lord J. M. Spontaneous neutrophil apoptosis involves caspase 3-mediated activation of protein kinase C-delta. J. Biol. Chem 1999; 274(52)37329–37334
  • Potter P. K., Cortes-Hernandez J., Quartier P., Botto M., Walport M. J. Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells. J. Immunol 2003; 170(6)3223–3232
  • Ricci-Vitiani L., Conticello C., Zeuner A., De Maria R. CD95/CD95L interactions and their role in autoimmunity. Apoptosis 2000; 5(5)419–424
  • Rieux-Laucat F., Le Deist F., Fischer A. Autoimmune lymphoproliferative syndromes: Genetic defects of apoptosis pathways. Cell Death Differ 2003; 10(1)124–133
  • Rodnan G. P., Benedek T. G., Medsger T. A., Jr., Cammarata R. J. The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis. Ann. Intern. Med 1967; 66(2)323–334
  • Ronchetti A., Iezzi G., Crosti M. C., Garancini M. P., Protti M. P., Bellone M. Role of antigen-presenting cells in cross-priming of cytotoxic T lymphocytes by apoptotic cells. J. Leukoc. Biol 1999; 66(2)247–251
  • Rosen A., Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases: Implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 1999; 6(1)6–12
  • Rustin M. H., Bull H. A., Ziegler V., Mehlhorn J., Haustein U. F., Maddison P. J., James J., Dowd P. M. Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis. Br. J. Dermatol 1990; 123(6)725–734
  • Santos L., Hall P., Metz C., Bucala R., Morand E. F. Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: Interaction with glucocorticoids. Clin. Exp. Immunol 2001; 123(2)309–314
  • Savici D., He B., Geist L. J., Monick M. M., Hunninghake G. W. Silica increases tumor necrosis factor (TNF) production, in part, by upregulating the TNF promoter. Exp. Lung Res. 1994; 20(6)613–625
  • Shevach E. M. Regulatory T-cells in autoimmmunity. Annu. Rev. Immunol 2000; 18: 423–449
  • Shukla A., Stern M., Lounsbury K. M., Flanders T., Mossman B. T. Asbestos-induced apoptosis is protein kinase C delta-dependent. Am. J. Respir. Cell. Mol. Biol 2003; 29(2)198–205
  • Siegel R. M., Muppidi J., Roberts M., Porter M., Wu Z. Death receptor signaling and autoimmunity. Immunol. Res 2003; 27(2-3)499–512
  • Silverstein A. M. Autoimmunity versus horror autotoxicus: The struggle for recognition. Nat. Immunol. 2001; 2(4)279–281
  • Simon A. K., Gallimore A., Jones E., Sawitzki B., Cerundolo V., Screaton G. R. Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodies. Cancer Cell 2002; 2(4)315–322
  • Society A. T. Adverse effects of crystalline silica exposure. Am. J. Respir. Crit. Care Med. 1997; 155: 761–768
  • Steenland K., Brown D. Mortality study of gold miners exposed to silica and nonasbestiform amphibole minerals: An update with 14 more years of follow-up. Am. J. Ind. Med 1995; 27(2)217–229
  • Steenland K., Goldsmith D. F. Silica exposure and autoimmune diseases. Am. J. Ind. Med 1995; 28(5)603–608
  • Subra J. F., Renier G., Reboul P., Tollis F., Boivinet R., Schwartz P., Chevailler A. Lymphopenia in occupational pulmonary silicosis with or without autoimmune disease. Clin. Exp. Immunol 2001; 126(3)540–544
  • Tewari M., Yu M., Ross B., Dean C., Giordano A., Rubin R. AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal. Cancer Res 1997; 57(18)4063–4069
  • Thibodeau M., Giardina C., Hubbard A. K. Silica-induced caspase activation in mouse alveolar macrophages is dependent upon mitochondrial integrity and aspartic proteolysis. Toxicol. Sci 2003; 76(1)91–101
  • Thorburn A. Death receptor-induced cell killing. Cell Signal 2004; 16(2)139–144
  • Tomokuni A., Otsuki T., Isozaki Y., Kita S., Ueki H., Kusaka M., Kishimoto T., Ueki A. Serum levels of soluble Fas ligand in patients with silicosis. Clin. Exp. Immunol. 1999; 118: 441–444
  • Utz P. J., Anderson P. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum 1998; 41(7)1152–1160
  • Vaishnaw A. K., Toubi E., Ohsako S., Drappa J., Buys S., Estrada J., Sitarz A., Zemel L., Chu J. L., Elkon K. B. The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations. Arthritis Rheum 1999; 42(9)1833–1842
  • Viard I., Wehrli P., Bullani R., Schneider P., Holler N., Salomon D., Hunziker T., Saurat J. H., Tschopp J., French L. E. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282(5388)490–493
  • Wallach D., Varfolomeev E. E., Malinin N. L., Goltsev Y. V., Kovalenko A. V., Boldin M. P. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 1999; 17: 331–367
  • Watanabe S., Shirakami A., Takeichi T., Ohara T., Saito S. Alterations in lymphocyte subsets and serum immunoglobulin levels in patients with silicosis. J. Clin. Lab. Immunol 1987; 23(1)45–51
  • Webb P. R., Wang K. Q., Scheel-Toellner D., Pongracz J., Salmon M., Lord J. M. Regulation of neutrophil apoptosis: A role for protein kinase C and phosphatidylinositol-3-kinase. Apoptosis 2000; 5(5)451–458
  • Whyte J., Artlett C., Harvey G., Stephens C. O., Welsh K., Black C., Maddison P. J., McHugh N. J. HLA-DQB1 associations with anti-topoisomerase-1 antibodies in patients with systemic sclerosis and their first degree relatives. United Kingdom Systemic Sclerosis Study Group. J. Autoimmun 1994; 7(4)509–520
  • Wu J., Wilson J., He J., Xiang L., Schur P. H., Mountz J. D. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest 1996; 98(5)1107–1113
  • Zhou X., Tan F. K., Xiong M., Milewicz D. M., Feghali C. A., Fritzler M. J., Reveille J. D., Arnett F. C. Systemic sclerosis (scleroderma): Specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts. J. Immunol 2001; 167(12)7126–7133

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.